The Africa CDC has reported that mpox has been detected in ten African countries this year, including Burundi and Rwanda, which are experiencing cases for the first time.

Mpox cases in Africa have surged by 160% in 2024, raising concerns about the lack of effective treatments and vaccines on the continent.

The Democratic Republic of the Congo (DRC) remains the hardest-hit nation, reporting over 12,000 cases and at least 470 deaths this year.

Notably, nearly 70% of mpox cases in the DRC are in children under 15, who account for 85% of deaths.

Reports indicate that a new, more deadly form of mpox has emerged in Congo, potentially with a 10% fatality rate and easier transmission.

The expanding outbreak is particularly concerning in displaced persons camps in Congo, where significant population movement exacerbates the situation.

In response to the outbreak, authorities in the Central African Republic are seeking public cooperation to help manage the spread of monkeypox, especially in remote areas.

The Central African Republic confirmed a new outbreak, with cases extending to its capital, Bangui.

Despite the ongoing outbreak, the World Health Organization has noted that no funding has been allocated to combat mpox in Africa.

While vaccines and treatments have been effective in Western countries, their availability in African nations, including Congo, is severely limited.

Mpox infections first gained global attention in May 2022, primarily affecting gay and bisexual men, with the responsible subtype identified as Clade II.